https://www.nbcnews.com/health/health-news/remdesivir-may-reduce-deaths-appears-work-better-certain-patients-n1233382
The new data found the most benefit for severely ill patients under age 65, people who didn't require as much oxygen and those who hadn't received biologic treatments used to tackle an overzealous immune response called a cytokine storm.
Black patients also seemed to do better than other groups. The findings, presented Thursday at a briefing ahead of the COVID-19 Conference at the AIDS 2020 Virtual Meeting, are further analysis of clinical trial results previously published in the New England Journal of Medicine.